Inc.’s stock price changed recently Upgrades and downgrades for HURA from analysts HURA’s stock price momentum as measured by its relative strength Before we jump into TuHURA Biosciences, Inc.’s stock ...
A 29-year-old man was seriously injured in a violent incident in the town of Hura on Monday evening. Magen David Adom paramedics provided him with medical treatment and evacuated him to Soroka ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Financially, HURA's cash burn rate suggests a need for additional funding, despite recent financing that extends cash runway into late 2025. Overall, HURA's high-risk profile and early-stage ...
TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company was founded on May 4 ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results